Lantern Pharma(LTRN) - 2022 Q3 - Earnings Call Transcript

Lantern Pharma Inc. (NASDAQ:LTRN) Q3 2022 Results Conference Call November 7, 2022 4:30 PM ET Company Participants Panna Sharma - President and CEO David Margrave - CFO Nicole Leber - Investor Relations Conference Call Participants John Vandermosten - Zacks Research Michael King - EF Hutton [Call Start Abruptly] shortly after the call. We issued a press release after market closed today, summarizing our financial results and progress across the company for the third quarter of 2022. A copy of this release i ...